Similarly, [68Ga]-FAPI-46 had a similar uptake in the tumor to FAP-2286, but FAPI-46 exhibited a faster clearance in the background tissue, providing an improved tumor-to-background ratio of 3–5 times more than that of FAP-2286 at early time points [6]. The gene discussed is FAP; the disease is neoplasm.